Dilip Harindran Vallathol

Kudos for the path breaking work from Head and Neck disease management team at TMH,Mumbai. This work on low dose immunotherapy has a special relevance in the current setting. May this work be thought provoking for future clinical trials in these lines. ascopubs.org/doi/abs/10.120…

Begs the question should we use PCV or TMZ. PCV with time tested results versus ease of TMZ. In lung for a lower absolute benefit we would give a similar cytotoxic therapy. @tmhmedoncalumni @groundhogcs @onconikhil @Diliphv86 @SimitSapkota @Nandinimenon18 @Amolpatel_dr

Data is from multiple randomised studies done in TMH. Thanks @Diliphv86 for the hard work.

Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial academic.oup.com/jnci/advance-a… @VanitaNoronha @Drsinghai @ISMPOofficial @tmhmedoncalumni @ACTREC_TMC Palliative care in HN cancer the first randomised study

sciencedirect.com/science/articl… An article in Lancet Global Health from our institute Tata Memorial Hospital on use of low cost oral metronomic chemotherapy in metastatic recurrent inoperable head and neck cancers especially useful in resource constrained low middle income countries